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As one part of the cellular response to DNA damage, an error prone polymerase 
(DNA polymerase V, composed of an UmuD'2-UmuC protein complex), conducts 
SOS mutagenesis in Escherichia coli. However, the protein UmuD present in 
Acinetobacter baylyi strain ADP! (UmuDAb) contains an extra N-terminal region. 
Furthermore, observations made in our lab have shown that ADPl does not respond 
to DNA damage by SOS mutagenesis because of the absence of umuC gene. 
UmuDAb upregulates the transcription of ddrR (a DNA damage-responsive gene) in 
ADPl. We are thus investigating the function of this UmuDAb in the DNA damage 
response. Since UmuD of E. coli self-cleaves around 20 minutes after DNA damage 
to carry out SOS mutagenesis, and UmuDAb disappears -20 minutes after mitomycin 
C (a DNA damaging agent) treatment, we hypothesize that UmuDAb also self-
cleaves in response to DNA damage. We have created a mutation in the predicted 
cleavage site ofUmuDAb. The mutated umuDAb gene was cloned into an expression 
vector and transformed into wild type, umuD, and recA strains of E. coli. 
Surprisingly, immunoblot analyses have shown that UmuDAb, mutated at the 
predicted cleavage site of ADP 1, still disappears after mitomycin C treatment when 
expressed in E.coli. We have also created a mutation in a Lys-156 residue that, in E. 
coli, activates nucleophilic attack mediated by serine at the predicted cleavage site. 
Immunoblot analyses have sho~n that UmuDAb that is mutated at the nucleophilic 
activator site does not disappear after mitomycin C treatment when expressed in E. 
coli. Our observations conclude that lysine residue is essential for the cleavage of the 
protein like in E. coli. Moreover, UmuDAb is expressed but does not disappear in 
recA strains, which suggests that RecA is required for the self-cleavage of UmuDAb 
after DNA damage like in E. coli. We thus speculate that UmuDAb cleaves in 
response to DNA damage and we are interested in studying the regulatory function of 
the cleaved UmuDAb in response to DNA damage. Future directions will involve 
more studies on the predicted cleavage site of ADP! as well as the serine residue that 
mediates the cleavage of the protein. 
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Introduction 
Genomic DNA replication is necessary for the continuity of life, but as 
various endogenous or exogenous factors can damage DNA, cells must implement a 
variety of DNA damage repair mechanisms in order to sense and repair these 
damages. There are two main ways cells can sense and repair damages: error-free and 
error-prone repair mechanisms. Error-free repair mechanisms, as the name implies, 
repair the DNA damage without creating any mutations while error-prone 
mechanisms repair the DNA at the cost of increasing mutation loads in the DNA. 
Most research has been performed in Escherichia coli model system. Nevertheless, 
different types of organisms, prokaryotes and eukaryotes, have evolved various types 
of DNA damage repair systems and mechanisms. The focus of the research is to study 
the error-prone repair system, specifically SOS mutagenesis, a type of error-prone 
repair mechanism that has been extensively studied in E. coli. 
This thesis will discuss different types of DNA damage and DNA damage 
repair systems. The SOS response system in E. coli and our developing information 
on a similar response system in Acinetobacter baylyi strain AD Pl which encompasses 
error-free and error-prone repair systems, will be discussed. Mainly, my thesis will 
test if there is cleavage in an SOS response protein, UmuDAb, of ADPl after DNA 
damage. With the help of mutations that I have created at the predicted cleavage site 
and nucleophilic activator site of the protein, this thesis work will primarily test if the 
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SOS response protein self-cleaves in response to DNA damage. UmuD of E. coli 
self-cleaves around 20 minutes after DNA damage to cany out SOS mutagenesis. 
Interestingly, UmuDAb also disappears ~20 minutes after mitomycin C (a DNA 
damaging agent) treatment, and we hypothesize that UmuDAb also self-cleaves in 
response to DNA damage. 
DNA damage 
Sources of DNA damage 
Sources of DNA damage can be either endogenous (within the cells) or 
exogenous (sources outside of the cells). Many naturally found factors as well as 
man-made artificial agents can induce DNA damage (Ames, 1979). Endogenous 
sources of DNA damage include errors that occur during DNA replication when 
proofreading function of DNA polymerases have failed to fix them. The cellular 
environment itself is thus a continuous source of DNA damage (Cassimeris et al., 
2010). A wide variety of chemical agents can alter specific bases within nNA. For 
example, reactive oxygen species such as hydroxyl radicals react with guanine to 
form 8-oxoguanine. 8-oxoguanine pairs with adenine instead of cytosine during DNA 
replication, which results in spontaneous transversion DNA mutations (Snyder et al., 
2007; Tropp, 2008). Deamination is another process that causes DNA mutation. For 
example, nitrous acid (HN02) can cause deamination by converting adenine to 
hypoxanthine, which can then base pair with cytosine rather than thymine to cause 
DNA mutation (Berge et al., 2007). 
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Nucleotide bases are also subject to alkylation in addition to oxidation and 
deamination. Alkylating agents include mitomycin C (MMC), aflatoxin B1, nitrogen 
mustard gas (bis[2-chloroethyl]methylamine) and ethylmethane sulfonate (EMS). 
MMC (See Figure 1 for structure) is a potent DNA crosslinker and crosslinking by 
MMC is specific for the duplex DNA sequence CpG•CpG (Tomasz, 1995). The 2-
NH2 group of the strand opposite to guanine is required for selective monoalkylation. 
The 2-NH2 group can form a hydrogen bond with the Cl0' oxygen of the activated 
MMC, and this non-covalent bond increases the rate of formation of the covalent 
bond with the target guanine (Tomasz, 1995) (Figure 2). Thus, the double helix 
structure of DNA can be distorted and results in replication arrest and cell death if the 
crosslink is not repaired. Other compounds such as psoralens produced by the 
Chinese herb, Psoralea corylifolia can form inter-strand cross-links, which also 
prevent replication and gene expression because the cross-linked strands cannot be 
separated (Berg et al., 2007). 
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Figure I. Mitomycin C Structure 
(Adapted from Webb et al., 1962) 
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Figure 2. DNA crosslink caused by MMC 
(Adapted from Tomasz, 1995) 
Base analogs resemble the normal bases in DNA and are sometimes 
converted into a deoxynucleotide triphosphate and become incorporated into DNA. 
The incorporation of a base analog such as 2'-aminopurine (2-AP), and 5'-
bromouracil (5-BU) can be mutagenic, as the base analog pairs with the wrong base. 
2-AP resembles adenine and pairs with thymine, while 5-BU is an analog of thymine 
and wrongly base pairs with adenine (Snyder et al., 2007). 
One of the major exogenous sources of DNA damage is radiation. Radiation 
can be subdivided into two types: UV radiation and ionizing radiation (X-rays and 
gamma rays). The ultraviolet (UV) component of sunlight is a DNA-damaging agent 
(Cassimeris et al., 2010). UV light functions by covalently linking adjacent 
pyrimidine residues (thymine-dimers) along a DNA strand. The intrastrand cross-
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linking causes a distortion of the double helix structure of DNA as pyrimidine dimers 
can fit into a double helix and completely block replication and gene expression 
(Berg et al., 2007). X-rays and gamma-rays cause a variety of DNA lesions and these 
lesions can be a result of direct damage to the DNA or indirect damage when the 
radiation produces reactive species such as reactive oxygen species (ROS) in the 
cells. Ionizing radiation is lethal to the cells and a double-strand break is the most 
common DNA damage caused by ionizing radiation (Cassimeris et al., 2010). 
Types of DNA damage 
Exposure of DNA to endogenous or exogenous DNA damaging sources 
causes mutations in DNA. The mutations result from changes in DNA sequence or 
deletions, insertions or rearrangement of DNA sequence. A base substitution is the 
simplest type of mutation, where a nucleotide pair in a DNA is replaced with a 
different nucleotide. Some base substitutions replace a pyrimidine base with another 
pyrimidine or one purine base with another purine base; these are called transition 
mutations. On the other hand, while a pyrimidine base is replaced with purine base or 
one purine base is replaced with pyrimidine base, the substitution is referred to as 
transversion mutations. The mutations in DNA sequence as a result of these base 
substitutions can change an amino acid sequence, truncate the protein, or shift the 
reading frame. 
A missense mutation or non-synpnymous mutation changes results in one 
amino acid being replaced with another and this replacement in a protein alters the 
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biological property of the protein. Diseases such as phenylketonuria and sickle-cell 
anemia are caused by missense mutations. A nonsense mutation is a base substitution 
that creates a new stop codon, making a polypeptide truncated. The premature chain 
termination renders the polypeptide non-functional. A silent or synonymous 
substitution changes the nucleotide sequence without changing the amino acid 
sequence. A silent substitution is so called because it is not detectable by changes in 
phenotype. In addition, a frameshift mutation caused by addition or deletion of a 
single base shifts the reading frames of the codons in mRNA. A frameshift mutation 
results in synthesis of nonfunctional protein as the frameshift alters the amino acids 
downstream from the site of mutation (Hartl et al., 2002). DNA damaging agents 
used in this study are UV radiation, which induces frameshift mutation in bacteria 
(Hartman et al., 1971; and Miller, 1985) and mitomycin C (MMC), which induces 
either a base substitution or a frameshift mutation (Minear et al., 1995). 
DNA damage a11d repair systems 
When a cell's DNA is damaged, the cell senses and respond to the DNA 
damage with activation of an error-free repair system or error-prone repair system 
(Figure 3). Most of the SOS genes are induced rapidly after DNA damage and are 
involved in an error-free DNA repair, such as base excision repair (BER), nucleotide 
excision repair (NER), and recombinational DNA repair (Friedberg et al., 2006). 
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Figure 3. DNA damage repair mechanism in prokaryotes. 
However, if the levels of DNA damage are tremendous, then error-free repair systems 
cannot repair the damage and the replication is halted. Now, the mutagenic phase of 
SOS response is triggered (Walker, 1984; Echols and Goodman, 1990). After sensing 
DNA damage, a cell's repair machinery attempts to fix the DNA damage and it may 
lead to the following scenarios: 1) the DNA is repaired perfectly, also known as error-
free DNA repair; 2) the damage cannot be repaired or the repair is incomplete and the 
cell undergoes apoptosis; and 3) the cell carries out error-prone repair with increased 
levels of mutations in DNA. 
Error-free DNA repair 
Most of the repair pathways can sense the initial DNA lesion and function by 
removing the lesion ( either a single base or larger area in the damaged region). The 
repair pathways then use the information on an undamaged complementary strand to 
synthesize nucleotides in the damaged area and thus restore the information content 
oftheDNA. 
In some cases, however, DNA damage can be simply reversed through the 
action of an enzyme such as photolyase. The system is called a direct repair system or 
photoreactivation repair system (Schul et al., 2002). The photoreactivation is so 
called because this type of repair occurs only in the presence of visible light. The 
photolyase enzyme uses the energy of an absorbed photon to directly bind to a cyclic 
pyrimidine dimer (CPD), which is the damaged area, and cleaves the cyclobutane 
ring, restoring the original normal structure of the pyrimidine monomers (Yasui et al., 
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1994 ). The damaged DNA can also be directly repaired in a second type of direct 
repair by the action of a group of enzymes known as alkyltransferases (Pegg and 
Byers, 1992). A wide variety of these enzymes with specificities for different types of 
lesions have been reported in prokaryotes (Cassimeris et al., 2010). One of the 
alkyltransferase enzymes, DNA glycosylase, can remove a variety of alkylated 
substrates. Alykltransferases restore the original structure of a base by transferring the 
alky group from a damaged base to themselves (Krokan ei al., 1997). The irreversible 
attachment of the alkyl groups makes these enzymes inactive, therefore these 
alkyltransferases are also known as "suicide enzymes" (Cassimeris et al., 2010). 
Sometimes wrong nucleotides are mistakenly inserted by DNA polymerase III 
into the newly synthesized strand of DNA during DNA replication. The incorrectly 
inserted nucleotides are then usually removed by an enzymatic DNA repair process 
known as DNA proofreading. DNA polymerase I acts as nuclease and recognizes and 
removes mismatched bases by hydrolysis at the 5' end of the mismatched nucleotide. 
Since DNA polymerase I has a 3'-5' exonuclease activity, the removal of a nucleotide 
at the 5' end results in a free 3' OH group in the preceding base; this allows for the 
insertion of a correct nucleotide (Liu, 2007). 
Another type of DNA damage repair mechanism, the excision repair system 
can be further sub-divided into three types: base-excision repair (BER), nucleotide 
excision repair (NER), and mismatch repair (MMR). BER removes bases damaged by 
alkylation, deamination, and oxidation (Cassimeris et al., 2010). Classes of enzymes 
known as DNA glycosylases (similar to alkyltransferases) and AP endonucleases are 
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the key players in the BER system. DNA glycosylase removes the damaged base 
from DNA and attaches it into an active site of the enzyme, and cleaves the N-
glycosyl bond of the deoxyribose. The next stage of the pathway is followed by 
cleavage of the phosphodiester backbone so that abasic [apurinic/apyrimidinic (AP)] 
sites left in the DNA can be removed and replaced. AP endonuclease recognizes the 
AP sites and cleaves the DNA backbone 5' to the AP site. As a result, there is a gap in 
the DNA with a 5'-deoxyribose phosphate and 3'-OH, which can then be repaired by 
DNA polymerase I and DNA ligase (Cassimeris et al., 20 I 0). 
On the other hand, the nucleotide excision repair (NER) removes a large -12 
base region containing a DNA lesion. The resulting gap is the filled in with 
nucleotides using the intact DNA strand as a template for DNA polymerase. A wide 
range of DNA lesions such as thymine dimers resulting from UV irradiation, 
aflatoxin-damaged bases, and DNA cross-links can be repaired by the NER pathway. 
A mutation in human nucleotide excision repair (NER) genes can cause a disease 
called xeroderma pigmentosum (XP), which leads to an 1,000 fold increase in the 
incidence of skin cancer (Cassimeris et al., 2010). 
The mismatch repair is a type of excision repair, which recognizes and repairs 
the DNA containing the mismatch by its replacement with the correct sequence using 
the complementary strand as a template. The major genes involved in MMR are 
mutH, mutL, and mutS (Cox, 1997). The MutH protein first binds to a mismatch and 
the MutL protein is recruited. The MutH-MutL complex then activates MutH 
endonuclease, which nicks the DNA at the nearest unmethylated GATC site (Iyer et 
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al., 2006). The nick acts as an entry point for helicase II to unwind the DNA 
containing the mismatch. Exonucleases degrade the unwound DNA containing the 
mismatch and DNA polymerase III fills in the resulting gap using the intact DNA 
strand as a template (Duckett et al., 1996). 
Error-pro11e DNA repair 
When error-free mechanisms cannot repair DNA damage, then error-prone 
repair systems come into play. The "SOS response" was first described and coined by 
Miroslav Randman in 1974 (Radman, 1974). The SOS response comprises over 20 
unlinked genes such as recA, lexA, umuDC, polB, recN, sulA, uvrA, uvrB, and uvrD 
(Friedberg et al., 1995) and are induced after a cell is exposed to a DNA-damaging 
agent such as UV irradiation or chemicals (Witkin, 1976; Walker, 1984). Most of the 
SOS genes are induced rapidly after DNA damage and are involved in error-free 
DNA repair, such as base excision repair (BER), nucleotide excision repair (NER), 
and recombinational DNA repair (Friedberg et al., 2006). The SOS response is an 
inducible system and encompasses error-free and error-prone functions. The error-
prone SOS response is responsible for mutagenic events that occur when DNA 
damage cannot be repaired in an error-free manner (Walker, 1984; Echols and 
Goodman, 1990) and thus is called SOS mutagenesis. 
When cells experience lethal DNA damage and error-free mechanisms cannot 
repair the damage but cells are under pressure to replicate, an alternate umuDC-
dependent process that leads to translesion synthesis (TLS) is induced (Bridges and 
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Woodgate, 1985; Sutton et al., 2000; Goodman, 2002). TLS repairs UV-induced 
DNA damages and induces errors in the general vicinity of lesions. The error-prone 
response system is usually the last inducible system in effect in response to DNA 
damage when error-free repair systems cannot cope with the damage (Lodish et al., 
2000). The umuC and umuD genes that act on SOS mutagenesis are turned on -30 
min after the cells have been exposed to UV (Sommer et al., 1998) 
These mechanisms of DNA repair such as error-free and error-prone repair 
mechanisms are also found in eukaryotes (Hubscher et al., 2002; Gan et al., 2008). 
Mutations in any of these DNA-damage repair pathways may lead to cancer in 
humans. 
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The SOS mutageuesis system 
SOS mutage11esis i11 E. coli 
The DNA damage in E. coli by agents such as UV light, mitomycin C, or 
fungal metabolites like aflatoxin BI generates a signal that activates RecA protein to a 
form (RecA *) that can promote the proteolytic self-cleavage of the LexA repressor 
(Horii et al., 1981). The result of the inactivation of LexA repressor by proteolytic 
cleavage is the increased expression of SOS genes such as umuD, umuC, recA (Little 
et al., 1982; Walker et at:, 1984) and many other SOS response genes such as polB, 
recN, sulA, uvrB, and uvrD (Friedberg et al., 1995). LexA is a repressor protein that 
negatively regulates the transcription of the SOS genes and other genes by binding to 
a 20 nucleotide "SOS box" (Lewis et al., 1992) in the promoters of these genes and 
interferes with the RNA polymerase transcription of the SOS response genes (Mount 
et al., 1972, and Brent et al., 1981). With the extensive amount of research done on E. 
coli 's SOS mutagenesis response, we know that Umu proteins play a causal role in 
damage-induced mutagenesis in E. coli (Steinborn, 1978; Kato et al., 1977). E. coli 
umu genes are found in an umuDC operon. The umuD gene is smaller in size and 
overlaps umuC gene by one base pair (Gonzalez et al., 2002). The umuD and umuC 
genes encode for proteins of 15.0 and 47.7 kDa, respectively (Kitagawa et al., 1985). 
RecA * also facilitates the cleavage of UmuD to its shortened form UmuD'. UmuD 
and UmuD' can bind to each other to form a heterodimer or combine with a copy of 
itself, forming a homodimer. The resultant heterodimer or homodimer can combine 
with UmuC, forming a variety of different complexes, including the error-prone DNA 
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polymerase V that carries out SOS mutagenesis. The Umu(D)2C complex participates 
in regulating the E. coli cell division cycle after DNA damage by slowing down the 
cell cycle and allowing more time for error-free repair mechanisms to act (Opperman 
et al., 1999). The UmuDD'C seems to be an inactive form and may play a role in 
shutting off SOS mutagenesis by binding with the UmuD'. The (UmuD')2C complex 
(the error-prone DNA polymerase V) (Figure 4) causes SOS mutagenesis (Tang et al., 
1999). Thus, the SOS mutagenesis system requires umuD+c+ and recA+ and allows 
the cells to replicate through unrepaired lesions in the template DNA that cannot be 
repaired in an error-free manner (Tang et al., 1999). The survival rate of the cells is 
increased while mutation rate is elevated as a result of the translesion synthesis 
(Friedberg et al., 1995; Sutton et al., 2000). 
There are two DNA polymerases that carry out SOS mutagenesis: DNA pol 
IV and DNA pol V. DNA pol IV was first discovered in 1999 and reported to be 
encoded by the SOS gene dinB (Wagner et al., 1999). DNA pol IV lacks intrinsic 3'-
5' exonuclease proofreading activity (Tang et al., 2000; Goodman, 2002). The fidelity 
of the DNA pol IV is achieved by its ability to differentiate between correct and 
incorrect base formation. In a normal cell, the level of DNA pol IV is approximately 
250 molecules per cell and this can increase up to IO-fold upon DNA damage (Kim et 
al., 2001) 
DNA pol V is a Y-family polymerase and is a major translesion synthesis 
(TLS) polymerase in E. coli (Goodman, 2002). Although DNA pol IV (dinB) is 
induced rapidly after DNA damage (Qiu et al., 1997 and Kim et al., 2001), DNA pol 
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V (UmuD'2C) is not detectable until 20-40 min post SOS induction (Sommer et al., 
1998). The delayed expression is useful to the bacterium because it provides an 
opportunity for the cell to repair the damaged DNA before the cells undergo 
mutagenic translesion synthesis (Pham et al., 2002). 
DNA pol V was also first identified in 1999 (Tang et al., 1999, and Reuven, et 
al., 1999) and is encoded by the umuDC locus. DNA pol V consists of a dimer of 
post-translationally cleaved UmuD' protein complexed with a monomer of UmuC 
(Woodgate, et al., 1989). The amount of DNA pol Vin a normal cell is 15 molecules 
per cell while it can reach 200 molecules per cell upon DNA damage (Woodgate et 
al., 1991). DNA pol V also lacks 3'-5' exonuclease proofreading activity, therefore it 
is considered a low fidelity DNA polymerase. DNA pol V is essential for most in 
vivo damage-induced SOS mutagenesis in E. coli because of its ability to bypass 
lesions when the replication fork is stalled due to lethal DNA damage. 
SOS Mutage11esis i11 11011-E. coli models 
SOS mutagenesis has also been studied in many different bacteria such as 
Bacillus (Love et al., 1984; Love et al., 1986), Mycobacterium (Movahedzadeh et al., 
1997), and Xanthomonas (Yang et al., 2002). Studies have shown that the SOS 
mutagenesis systems found in these bacteria are similar, but not identical, to that of E. 
coli. 
The SOS box and LexA repressor proteins are found to be conserved among 
these bacteria. The recA gene has been found in all sequenced eubacterial genomes 
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(Campoy et al., 2002). RecA protein possesses the following wide range of functions 
in different bacterial species: 1) the homologous DNA pairing and strand exchange 
with a homologous duplex of DNA (Lusetti and Cox, 2002), 2) induction of SOS 
response (Walker et al., 2000), and 3) interaction with the mutagenic proteins to carry 
out translesion synthesis (Bridges and Woodgate, 1985; Goodman, 2002). Proteins 
homologous to RecA are found in both archaea and eukaryotes. In archaea, the RecA 
homolog is called RadA (Seitz et al., 1998; Yang et al., 2001; Wu et al., 2004), while 
two RecA homologs, Rad51 and Dmcl proteins are found in eukaryotes (Bishop et 
al., 1992; Shinohara et al., 1992; Sung, 1994). In contrast, the number of lexA genes 
present in bacteria is variable, ranging from zero in Helicobacter pylori (Campoy et 
al., 2002) to two in Xanthomonas axonopodis pathovar citri (Yang et al., 2005). In 
addition, the SOS box sequences are also found to vary between different bacterial 
classes, such as TACTG(TA)sCAGTA for E.coli (Walker, 1984), TTAG(N6)TACTA 
for Xylellafastidiosa (Campoy et al., 2002), CCAACRNRYGTTCYC for B. subtilis 
(Winterling et al., 1998), and GGTT(N2)C(N4)G(N3)ACC for Geobacter 
sulfurreducens (Jara et al., 2003). Interestingly, no sequence similar to known SOS 




.. umuDC , .. 
!RecA::ssCNA fllement 
' f umuDC 
t '.C\D£\.ry+ .. 
I RecA::ssDNA + mament 








Figure 4. SOS response and UmuD action in E. coli. A dimer of UmuD' modified post-translationally forms a 
complex with a monomer of UmuC protein. The complex is a DNA polymerase V, which can bypass lesions in a 
DNA [leading to translesion synthesis {TLS)]. This figure is copied from Ferentz et al., 200 l. 
Acinetobacter 
General microbiology 
Acinetobacter are Gram-negative, strictly aerobic, non-fermenting, non-
fastidious, non-motile, catalase-postitive, oxidase-negative, coccobacillary 
gammaproteobacteria with a G+C content of 39% to 47% (Rossau et al., 1991). 
Members of the Acinetobacter genus are considered ubiquitous organisms in the 
environment; they can be abundantly recovered from virtually all samples such as soil 
and surface water (Baumann et al., 1968). Members of the Acinetobacter genus have 
been historically classified by various researchers under numerous different 
taxonomic names such as Bacterium anitratum; Here/lea vaginicola, Mirna 
polymorpha; Achromobacter, Alcaligenes, Micrococcus calcoaceticus, and 
Moraxella glucidolytica and Moraxella lwofjii (Bergogne-Berezin et al., I 996); at 
present the genus Acinetobacter is classified in Phylum Proteobacteria, Class 
Gammaproteobacteria, Order Pseudomnadales, and Family Moraxellaceae. 
Members of Acinetobacter species are typically non-pathogenic; however pathogenic 
strains of A. baumannii (Peleg et al., 2008), A. lwojji (Rathinavelu et al., 2003), A. 
ursingii, A. schindlerii (Nemec et al., 2000), and A. baylyi (Chen et al., 2008) have 
been reported. 
Some of the bacterial species of Acinetobacter, such as A. baumannii are 
increasingly becoming a source of hospital-acquired infections (Peleg et al., 2008). 
The resistance of A. baumannii to disinfectants and its ability to survive for a 
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prolonged period of time in a hospital environment helps the organism in nosocomial 
spread (Peleg et al., 2008). The ability of A. baumannii to upregulate or acquire 
resistance determinants makes it one of the most important species of clinical 
relevance. Strains of A. baumannii have been found to be resistant to most of the 
known clinical antibiotics (Peleg et al., 2007), which requires this species to be added 
to the list of organisms challenging the modem antibiotic era. A. baumannii are 
commonly associated with hospital acquired pneumonia and wound infections but 
currently the incidence of infections involving the nervous system, skin and soft 
tissue, and bone appears to be increasing (Peleg et al., 2008). 
General features of ADPJ for being a good model organism 
Acinetobacter baylyi strain ADPI is a ubiquitous soil and aquatic bacterium 
and has a capacity for natural transformation during late log phase (Young et al., 
2005). Because Acinetobacter spp. can use a variety of carbon sources, they can be 
grown on simple media in lab (Barbe et al., 2004). With an optimal temperature 
between 30°C and 37°C, ADP! can even grow slowly in room temperature (Metzgar 
et al., 2004). Because of its relatively small genome size of 3. 7 Mbp, which has 
recently been sequenced (Barbe et al., 2004), ADPI 's genes can be readily 
manipulated in the lab. Moreover, ADPI is a good candidate as an industrial 
microorganism because they are harmless to humans as they do not carry any genes 
classically associated with pathogenesis or virulence (Barbe et al., 2004). Moreover, 
several antibiotics that are commonly used against E. coli are also effective against 
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ADP 1, and many antibiotic resistance cassettes used in E. coli can also be transferred 
in ADPl with ease (Kok et al., 1995). Additionally, ADPl 's property of natural 
competence (Young et al., 2005) and a natural tendency toward homology-directed 
recombination (de Vries et al., 2002) makes it a comparatively superior candidate 
over E. coli for research involving genetic manipulation. ADPl in their exponential 
growth phase are approximately 10-100 times as competent as calcium chloride 
treated competent E. coli (Metzgar et al., 2004). All of these characteristic features of 
ADPl point to the fact that ADPl is an excellent bacterial model and surpasses the 
expectations of E. coli. Furthermore, as a non-enteric gammmaproteobacteria, ADPl 
is an excellent model to examine basic cellular processes other than E. coli. 
DNA damage response in Aci11etobacter 
Acinetobacter sltares features witlt E. coli i11 respo11se to DNA damage 
After DNA damage, at least two DNA damaging response genes are induced 
in ADPl: ddrR (DNA damage-responsive gene) and recA (Hare et al., 2006; Rauch et 
al., 1996). In its response to DNA damage, ddrR requires RecA for induction 
(Whitworth et al., 2000). However, ADPl shows some unique.features in response to 
DNA damage. ADPl does not respond to DNA damage with SOS mutagenesis 
(Berenstein, 1987). The recA gene is induced by DNA damage in ADPl as in E.coli, 
but unlike in E. coli, the induction of recA does not require the RecA protein (Rauch 
et al., 1996). Moreover, several E. coli DNA damage proteins such as DinB, cr38, 
SulA, FtsEX, and LexA are not found in Acinetobacter spp. (Robinson et al., 2010). 
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A. baylyi strain ADPl MutS protein has been shown to recognize mismatches 
that arise during DNA replication and homologous recombination similar to E. coli 
(Young et al., 2001 ). The MutS protein preferentially recognizes transition 
mismatches and 1-bp frameshifts. However, the protein does not recognize neither 
transversion mismatches nor large insertions or deletions (Young et al., 2001 ). 
Absence of LexA and SOS box 
The ADPl recA and ddrR promoters lack a known SOS box (Gregg-Jolly et 
al., 1994; Hare et al., 2006). ddrR is encoded next to the 'extra-long' UmuDAb in 
many Acinetobacter species, especially in A. baumannii (Personal communication 
with J. Bradley and J. Hare). Furthermore, there is absence of a LexA homolog in 
APDl. This means that umuDC operon in ADPl is constitutively expressed and is not 
regulated by DNA damage or recA (Hare et al., 2006). 
ADP] and other bacteria have "extra-long" UmuD 
The umuDAb gene found in A. baylyi has an extra N-terminus region unlike E. 
coli and other bacteria. The umuDAb gene of ADPl is 612 bp long and encodes·a 
gene product of 203 amino acids, while the umuD gene found in E. coli and other 
bacteria encodes 140 amino acids (Figure 5). The umuD found in ADP 1 is thus about 
1.5 times the size of umuD in E. coli and other bacteria (Hare et al., 2006). This 
means that umuDAb gene of ADPl has a capacity to encode a larger protein and this 
larger size may be what carries out a different regulatory response to DNA damage 
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than umuD of E. coli. Research has shown that the functioning of the umuDAb 
encoded gene product is unlike other bacteria such as E. coli (Hare et al., 2006). 
Other bacteria such as Synechococcus elongatus, Legionella pneumophila 
strain Lens, and Chromobacterium violaceum have "extra-long" UmuD similar to 
ADP! (Figure 8). The function of these "extra-long" UmuD homologs have not been 
studied in these bacteria but their sequence was identified in the sequenced genomes 
(Hare et al., 2006). 
umuC of ADP] is mutated 
The umuC gene of ADP! is interrupted and incomplete, and there is also an 
insertion sequence fragment in between the interrupted umuC gene fragments (Figure 
5; Hare et al., 2006). The umuC fragments together contain 43% of the length of E. 
coli umuC gene (Hare et al., 2006). The 348-bp fragment of umuC is positioned 5.9 
kbp downstream of umuDC, which encodes 114 amino acids of UmuC with 28% 
identity to UmuC (Hare et al., 2006). The mutated umuC gene encodes 39 amino 
acids with 85% identity to the amino-terminal end ofUmuC. The umuC fragments are 
interrupted by a putative transposase gene, which is 72 bp long and is homologous to 
ISEhe3, and is found in the opposite orientation (Hare et al., 2006). Moreover, ADP! 
does not respond to DNA damage by SOS mutagenesis (Hare lab, data not shown), 
which correlates with the fact that ADP! has a mutated umuC. This feature of ADP! 
is unusual when compared to E. coli model system. Thus, experiments performed in 
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ADPl and its DNA damage response system might give us new insights into how 











Figure 5. Differences in AD Pl from E. coli model. The umuDAb is 1.5 fold longer than umuD. The umuC gene of ADPI 
is interrupted and incomplete, and there is also a presence of insertion sequence fragment in between the interrupted umuC 
gene. A genetic locus, ddrR is present in ADPI, which has no homologs in E. coli or any other bacteria. This figure is 
adapted from Hare et al., 2006. 
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SOS proteins UmuD and LexA belong to a serine-protease family that self-
cleaves 
UmuD and LexA both belong to a serine-protease family that uses a serine-
lysine catalytic dyad mechanism that helps in the self-cleavage of the protein (Paetzel 
et al., 1997). The Ser-119 and Lys-156 residues ofLexA are key residues needed for 
this cleavage (Little, 1991 ). First, the Ser-119 acts as a nucleophile and attacks the 
peptide bond in the cleavage site. Second, the uncharged Lys-156 acts as an activator 
by helping a proton to leave the serine hydroxyl group by donating a proton to the 
leaving amino group. Activated RecA (RecA *) facilitates this cleavage of LexA by 
lowering the pK. of the Lys-156 residue and thus indirectly helps in the cleavage of 
LexA (Figure 7). The peptide bond is now cleaved and a covalent ester intermediate 
is formed (Little, 1991 ). 
The percent identity between MucA, a UmuD homolog and the putative UV 
protection protein of Salmonella enteria serovar Typhi (Horii et al., 1981) and LexA 
is -28%, while UmuD is 31 % homologous to amino acids in the COOR-terminal 
domain of LexA (Perry et al., 1985) (Figure 6). E. coli UmuD is 140 amino acids and 
shares carboxyl-terminal homology with LexA (Walker, 1996). The sequence 
homology between UmuD and LexA suggests that RecA * interacts with UmuD 
(Perry et al., 1985). Firstly, RecA * initiates the proteolytic cleavage of LexA. 
Secondly, the interaction of RecA * with UmuD results in the post-translation 
cleavage of UmuD, which precedes in a similar fashion as that of LexA repressor. 
RecA * is also thought to play a role in helping UmuD dire.ct to its site of action 
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(Perry et al., 1985). The post-translation cleavage of UmuD is essential as only the 
dimer of UmuD' complexes with UmuC to form DNA pol V to carry out SOS 
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Figure 6. Homology of UmuD aud MucA proteins to the LexA protein. Underlined amino acids indicate the identities 
between the LexA repressor and either the UmuD or MucA proteins. The Ala-Gly cleavage site of LexA is between amino 
acids 112 and I 13 while the Cys-Gly putative cleavage site of UmuD is between amino acids 24 and 25. Adapted from 
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Figure 7. Mechanism ofLexA repressor cleavage. Ser-119 and Lys-156 are essential for effective cleavage of the 
LexA repressor. RecA* is thought to play a role in the cleavage by lowering the pKa ofLys-156. UmuD cleavage 
after DNA damage is also assumed to proceed by a similar mechanism. This figure is adapted from Little, 1991. 
Does UmuDAb self cleave after DNA damage? 
Studies have showu as mentioned above, that after DNA damage UmuD gets 
expressed in E. coli, and then self-cleaves post-translationally to form truncated 
UmuD'. A dimer ofUmuD' can then combine with UmuC protein to form DNA pol 
V, which can then carry out SOS mutagenesis. Similarly, in ADP!, at least two DNA 
damaging response genes are induced in ADP!: ddrR (DNA damage-responsive 
gene) and recA (Hare et al., 2006). The induction of ddrR is dependent on the 
activation of UmuDAb. Therefore, the question we pose is: Does UmuDAb self-
cleave to induce ddrR? To understand if UmuDAb indeed regulates ddrR expression 
after DNA damage, there is therefore a need to examine whether a self-cleavage of 
UmuDAb occurs after DNA damage. 
Goals for the thesis 
The possible cleavage ofUmuDAb in A. baylyi's response to DNA damage is 
poorly understood. However, UmuDAb contributes. to DNA damage response by 
regulating ddrR. But we do not know if UmuDAb self-cleaves in response to DNA 
damage like E. coli UmuD or if such self-cleavage is required for its regulation of 
ddrR. Therefore, as a first step, we are interested in studying whether UmuDAb self 
cleaves when induced to DNA damage or how UmuDAb behaves in response to 
DNA damage. At the same time, we are also interested in examining the effects of 
changing amino acid encoded by umuDAb on the potential cleavage of the gene 
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product after inducing the cells to DNA damage. This will tell us if cleavage, if it is 
indeed happening, proceeds like in the E. coli model. 
The cleavage site of E. coli UmuD is the bond between Cys-24 and Gly-25 
(Perry et al., 1985). Nohmi et al (1988) observed that by changing the Gly-25 residue 
of the putative Cys-Gly UmuD cleavage site to a glutamic acid or lysine residue 
significantly reduced the ability of UmuD to function in SOS mutagenesis. Changing 
the Cys-24 to a tyrosine residue caused a less severe reduction in the ability ofUmuD 
to functiqn in UV mutagenesis. Moreover, changing either Ser-60 or Lys-97 to an 
alanine residue drastically reduced the ability of UmuD to function in UV 
mutagenesis. Changing Ser-60 to a cysteine residue resulted in a less severe reduction 
in UmuD's ability to function in UV mutagenesis than the Ser-60 to an alanine 
residue change (Nohmi et al., 1988). 
UmuDAb, the UmuD homolog of A. baylyi has many amino acids that 
involved in nucleophilic attack at the Cys24-Gly25 in E. coli and the lysine-97 that 
assists are essential in E. coli for Rec-A facilitated UmuD self-cleavage. Serine-60, 
which is in the nucleophilic attack are well conserved in UmuDAb. The putative 
cleavage site in UmuDAb is Ala83-Gly84 (Hare et al., 2006) unlike Cys24-Gly25 in 
UmuD of E. coli. However, studies have shown that the cysteine in UmuD when 
substituted for alanine, did not affect the biological function of the umuD gene 
product (Lee et al., 1994 ). This observation leads us to an assumption that the UmuD 
and UmuDAb behave in an identical way. However, future studies will examine the 
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function and regulatory characteristic of the extra N-terrninus ammo acids of 
UmuDAb. 
Multiple sequence alignment of UmuD and UmuD homologs suggests that 
alanine-83/glycine-84 is the cleavage site of UmuDAb since the serine and lysine 
residues needed for cleavage are conserved in E. coli UmuD and UmuD homologs in 
other bacteria (Figure 8). A helpful way to illustrate if the predicted cleavage site in 
UmuDAb is indeed where the protein cleaves would be to create different types of 
mutations in either the cleavage site or the residues that are essential for cleavage. 
The three goals of my project are to: 1) study expression and cleavage of normal 
UmuDAb after DNA damage, 2) mutate alanine in the putative Ala-Gly cleavage site 
to glutamic acid and study the expression of the mutated gene product in E. coli wild 
type and recA strains by Western analyses, and 3) mutate the lysine to alanine in the 
nucleophilic activator residue that helps in the cleavage of UmuD and study the 
expression of similar E. coli wild type and recA strains. 
In this study, UmuDAb and its mutant versions will be expressed in E. coli 
because we understand how SOS mutagenesis occurs in E. coli. E. coli can uptake the 
plasmids with the umuDAb gene or any gene of interest easily. It is helpful for us to 
study about a protein in an E. coli model system where majority of pathways are 
understood rather than in ADP! where less is known about different metabolic and 
physiologic pathways. The ease of obtaining different mutant strains of E. coli such 
as umuD and recA also make E. coli an excellent model system for us in order to 































CvioUmuo (191 J 
l 66 I 
MSOONKNEHGGARTNA.GRKA.K---'YQEPTKV:X:RVPESQVAF:I:KRWLLDNVKTONLI:DFNSALKVQA 
--------------------------------------------------------------MLFL -------------------------------------------------------MSVSLZGRSGA ------------------------------------------------------------MALDLV 
-------MKGGJ\fu~GAGRPKGSGKYGEPTKAVRLPLSVIEQIPQIL--EQRS------SRTTLSEV 
-----MSPRGGKREGJ\GRPR-----GEPTKAVRXPLS------------------------OLi'\KL 
MDTDKPKQH GGKRSGAGRKSVFG- - GDKTV AVRVPEP LKP J: LOQO"lL- -ODYRSWRT1'\NSAQ1'\.FDFR 
XQPNPTKIYOJ:;LJ\TERVi~-;s;;QEHVEQSLO~NEYLVRNENA;FI.VKA~SL-~LOAG;oro~ 
KPADLRE:IVTFPL1-·so1.vc CG ~PSPAADYVEORIDLNQLLI.OHPSATYFVKASGO :-1:IDGGISDGD 




TLG1"'t.OLSELSLPLF.1\GSVI'~ SPVPADDLKETDXDLNTHLVSRPGOTFMVKVKGD MQGl\.GXHOGO 
PLI:VDRSITAKAGDIVXA..~DN'EF~,;,c L:-II0)iHFHPPKV'"dLKAENPDf"QNl:YTDEGQELVIWGVV 
LLIVOSJ\.ITJ\SHGO:IVIAAVDGEFT'\, LdLP.;-----PTVQL'IPXNSJ\YSP'ITISSEOTLDVFGVV 












Figure 8. Multiple alignment of UmuD homologs in different bacterial strains. The serine and lysine residues (second 
and third boxes) required for self-cleavage ofUmuD in E. coli are well conserved in UmuDAb and other UmuD homologs. 
The cleavage site of E. coli UmuD is the bond between Cys-24 and Gly-25, while the multiple alignment suggests that the 
predicted cleavage site ofUmuDAb is the bond between Ala-83 and Gly-84. This figure is adapted from Hare et al., 2006. 
Methods and Materials 
Bacterial strains 
The bacterial strains used in this project are listed in Table 1: Acinetobacter 
baylyi strain ADP!, AB! 157 (Escherichia coli K-12 wild type), AB2463 (E. coli 
recA13, isogenic to AB1157), 315 (E. coli umuD·, isogenic to AB1157), DH5a (E. 
coli recA") and, XL-10 Gold Ultracompetent cells. 
All of the bacterial strains examined in this study were grown in nutrient agar 
(NA) or Luria-Bertani (LB) broth or tryptic soy broth (TSB). All of the bacterial 
strains were grown at 37°C. 
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Table 1. Bacterial strains used in this study 
Strains Description Relevant Characteristic(s) Source Reference 
ADP! Acinetobacter Wild type Gregg- Personal 
baylyi Jolly lab communication with 
L. Gre1m-Jolly 
AB1157 Escherichia coli F-, thr-1, araC14, leuB6(Am), L1(gpt-proA)62, Walker lab Dewitt et al., 1962 
K-12 lacYl, tsx-33, qsr'-0, glnV44(AS), ga/K2(Oc), & 
lambda·, Rac-0, hisG4(Oc), ,jbCl, mgl-51, 
rpoS396(Am), psL3l(strR), kdgK51, xy/A5, 
mtl-1, argE3(Oc), thi-1 
AB2463 E. coli recAl 3 0, glnV44(AS), ga/K2(Oc), &lambda·, Rac-0, Gregg- Howard-Flanders et 
(isogenic to hisG4(Oc), ,jbCl,mgl-51, recA13, rpoS396(Am), Jolly lab al., 1966) 
AB1157) rpsL3l(strR), kdgK51, xy/A5, mtl-1, argE3(Oc), thi-1 
315 E.coli F-, thr-1, araC14, leuB6(Am), L1(gpt-proA)62, Walker lab Unpublished, 
umuD:kanR lacYl, tsx-33, qsr'-0, glnV44(AS), ga/K2(Oc), & personal 
(isogenic to lambda·, Rac-0, hisG4(Oc), ,jbCl, mgl-51, communication with 
AB! 157) rpoS396(Am), rpsL3l(strR), kdgK51, xy/A5, mtl-1, P. Buening of the 
argE3(Oc), thi-1, umuD:ka11R Walker lab 
DH5a E. coli recAl fhuA2 l':,.(argF-lacZ)Ul69 phoA glnV44 Invitrogen 
<JJ80 l':,.(lacZ)Ml 5 gyrA96 recAl re/Al endAl thi-1 
hsdR17 
XL-10 E.coli Te{!':,.(mcrA)l831':,.(mcrCB-hsdSMR-mrr)l73 endAl Stratagene 
Gold supE44 thi-1 recAl gyrA96 re/Al lac Hte [F' proAB 
lacl qZl':,.Ml 5 Tnl 0 (Te{) Amy Cam' 
Plasmids used 
The plasmids used in this project are listed in Table 2. The pJHI plasmid 
contains 2.2 kbp ADP! chromosomal DNA encompassing the umuDC operon and the 
ddrR locus cloned into pUC19, which confers ampicillin resistance (Hare et al., 
2006). The pJHI plasmid presumably contains a promoter 5' upstream of umuD. 
Construction of plasmids pIX-1 and plX-2 was based upon pJHI. 
QIAGEN's EasyXpress Protein Synthesis Kit was used to construct the 
plasmids plX-1 and plX-2 that carry the umuDAb gene from pJHI and which were 
used in the Kit's two-step PCR process for generating PCR products for in vitro 
translation. The first round PCR uses sense and antisense primers that bind to the 
umuDAb open reading frame (ORF) and adds extra 'attachment' base pairs for round 
2 PCR. In round 2 PCR, the adapter primers provided by the kit that encode an N-
terminal histidine tag or affinity tag attach to the 'extra' bp from round I PCR. The 
adapter primers add a T7 promoter, ribosomal binding site, and T7 transcription 
terminator. The overall two-step PCR process results in PCR products that contain 
multiple cloning sites well-suited for cloning into the EasyExpress plX3.0 vector. The 
PCR products, once cloned into pIX3.0 (Qiagen), can produce larger amounts of 
protein in large scale in vitro reactions. Another benefit of this cloned expression 
construct is that the expression construct can be used to transform E. coli cells for 
conventional in vivo expression. The pIX-1 and plX-2 plasmids were constructed by 
G. Howington and S. Wheeler in 2009. The plX-2 plasmid contains the 612 bp ORF 
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of umuDAb plus a ribosomal binding site, and T7 terminator cloned into QIAGEN's 
EasyExpress plX3.0 vector and thus encodes a N-terminus histidine-tagged 
UmuDAb. The plX-1 plasmid contains the 612 ORF of umuDAb cloned after T7 
promoter in the pIX3.0 vector, but encodes no histidine-tag in either the N- or C-
terminus ofUmuDAb. 
Both plasmids plX-2GtoE and pIX-2KtoA are derived from plX-2. The 
plasmid plX-2GtoE constitutively expresses UmuDAb that has a mutation in its 
predicted cleavage site (Gly-84➔Glu). Similarly, the plasmid plX-2KtoA 





Table 2. Plasmids used in this study 
Plasmids Description 
pJHl -2·.2 kbp Acintobacter baylyi strain ADP! chromosomal DNA encompassing the 
umuDC operon and ddrR locus cloned into the ampicillin resistant pUC19 cloning 
vector 
pIX-1 612 bp ofpIX3.0 containing umuDAb plus a T7 promoter, ribosomal binding site, and 
T7 terminator, no affinity tag 
pIX-2 612 bp ofpIX3.0 containing umuDAb plus a T7 promoter, ribosomal binding site, and 
T7 terminator, N-terminus histidine-ta!!!!ed 
pIX-2GtoE 612 bp ofpIX3.0 containing umuDAb plus a T7 promoter, ribosomal binding site, and 
T7 terminator with predicted cleavage mutation, N-terminus histidine-tagged, derived 
from pIX-2 
pIX-2KtoA 612 bp pIX3.0 containing umuDAb plus a T7 promoter, ribosomal binding site, and T7 
terminator with nucleophilic activator mutation, N-terminus histidine-tagged, derived 
from pIX-2 
Source 





Making mutations in UmuDAb 
In previous experiments performed by Nohtni et al. (1987), a mutation from 
glycine to glutamic acid at the second amino acid residue of the C24-G25 cleavage site 
of E. coli UmuD reduced SOS mutagenesis drastically. Similarly, a mutation of the 
nucleophilic activator residue lysine to alanine had a severe effect on SOS 
mutagenesis. So, mutations were constructed at these locations in UmuDAb, using the 
QuickChange™ Site-Directed Mutagenesis System (Stratagene, CA), a common and 
widely applicable PCR-based protocol for creating site-directed mutations. 
The plasmids pIX-2 or pJHl were PCR amplified with the sense and antisense 
primers and other contents as shown in Table 4. The designed primers are 
complementary to the opposite strands of the plasmids. These primers are extended 
by PfuTurbo DNA Polymerase during the temperature cycling of the procedure. The 
aillplified PCR products were restriction digested with Dpnl to get rid of original non-
mutagenized parental DNA and were transformed into XL- IO Gold Ultracompetent 
cells (Stratagene ). The mutagenized plasmids, after purification from XL-10 cells, 
were transformed into E. coli wild type (AB1157) and umuD strains (315) and 
selected on 100 µg/mL ampicillin media plates. 
Primer Design 
The primers for the site-directed mutagenesis were designed usmg the 
QuickChanage™ Site-Directed Mutagenesis Kit (Stratagene, catalog no. 200518) 
instruction manual, which was used to follow the parameters of the sense and 
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antisense primers. An automated tool at the Agilent website was used to design the 
primers (http://www.genomics.agilent.com). The umuDAb sequence (ACIAD2729) 
(Barbe et al., 2004, and www.genoscope.cns.fr/agc/mage/acinetoscope), was used as 
a template for designing primers. When designing a primer for mutagenesis purposes, 
these characteristics must be strictly followed: I) Both of the forward and reverse 
primers must be contain the desired mutation and anneal to the sequences on opposite 
strands of the plasmid; 2) Primers should be between the lengths of 25 & 45 bases; 3) 
Primers should have a melting temperature (Tm) of::: 78°C, 4) The desired mutation 
should be in the middle of the primer with- 10-15 bases of the correct sequence on 
both sides; 5) The primers should have a minimum GC content of 40% and preferably 
terminate in one or more G or C bases; 6) Primers must be purified by 
polyacrylamide gel electrophoresis (PAGE) or high-performance liquid 
chromatography (HPLC) (QuickChange™ Site-Directed Mutagenesis Kit). 
After their design, primers were constructed and purchased from Integrated 
DNA Technologies. The forward and reverse primers fo~ the mutated glycine to 
glutamic acid residue in the cleavage site were g181a_tl82gS and g18la_t182gAS 
respectively. Similarly, forward and reverse primers K97 ASense and K97 AntiSense 
were constructed and purchased for the mutated lysine 156 to alanine nucleophilic 
activator residue mutation. The mutation primers used in this study to create site-
directed mutagenesis are listed in Table 3. 
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Table 3. PCR primers designed for the site-directed mutagenesis 
Name of primer Purpose Sequence 
gl8la_t182gS Forward primer for 5'-CAGAACGTGTTGCTGCTGAGTTGCCATCACCTGCACAG-3' 
mutation of glycine to 
glutamic acid residue at the 
predicted cleavage site 
gl8la_tl82gAS Reverse primer for 5'-CTGTGCAGGTGATGGCAACTCAGCAGCAACACGTTCTG3' 
mutation of glycine to 
glutamic acid residue at the 
predicted cleavage site 
K97ASense Forward primer for 5'-GTTGACAATGAGTTTACGGTAGCCCGTCTGATGATCGATCATC-3' 
mutation oflysine to 
alanine residue at the 
nucleophilic activator site 
K97 AntiSense Reverse primer for 5'-GATGATCGATCATCAGACGGGCTACCGTAAACTCATTGTCAA-3' 
mutation of lysine to 
alanine residue at the 
nucleophilic activator site 
PCR Amplification 
The purpose of PCR amplification was to produce large amounts of mutated 
DNA products from a small amount of the original, wild type DNA encoding umuD. 
The sample reaction was prepared as follows: 
Sample Reaction Preparation 
The following contents were placed in a thin walled 0.2 mL PCR tube and 
amplified in a Veriti™ 96 Well Thermal Cycler (Applied Biosystems, CA). 
Table 4. Preparation of sample reaction for PCR cycler 
Amount(µL) Ingredient Comment 
5 1 OX reaction buffer 
3.78 dsDNA template, 1 0ng/µL Either pIX-2 or 
pJHl 
10 Oligonucleotide #1, final Forward primer 
concentration of 125rn,/10 uL 
10 Oligonucleotide #2, final Reverse primer 
concentration of 125n!!/10 µL 
1 dNTP mix, 25mM 
20.22 ddH2O 
1 PfuTurbo DNA polymerase (25 
U/µL) 
After the PCR tubes were placed in the PCR thermal cycler, an amplification 
reaction was run with the parameters as shown in Table 5. 
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Table 5. Cycling parameters for the QuickChangeTM site-directed mutagenesis 
method 
Segment Cvcles Temperature Time 
1 1 95°c 30 seconds 
2 16 95°c 30 seconds 
5s 0 c 1 minute 
68°C 5.5 minutes 
Following temperature cycling, the reaction was placed on ice for 2 minutes to 
cool the reaction to 2:: 3 7°C. 
10 µL of PCR product was mixed with loading dye and run in a 0. 7% gel. 
Lambda DNA cut with HindIII was used as a molecular weight marker. The 
remaining PCR product was digested with Dpnl. 
Dpnl digestio11 of the a111plijicatio11 products 
The purpose of Dpnl digestion is to allow the mutagenized plasmid to be 
transformed but not the original parental plasmid. The parental methylated DNA is 
digested by Dpnl and the PCR products remain intact because the newly synthesized 
DNA is non-methylated. This step ensures us that only the mutagenized plasmid is 
transformed. 1 µL of the Dpnl restriction enzyme (10 U/µL) was added directly to 
each of the amplification reactions. Each reaction was gently and thoroughly mixed 
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by pipetting the solution up and down (6-8 times). The reaction mixtures were spun 
down in a microcentrifuge for 1 minute and were incubated at 3 7°C for 1 hour. 
Tra11sformatio11 of XL-IO Gold Ultracompete11t cells 
The XL-10 Gold Ultracompetent cells (QuickChange® XL Site-Directed 
Mutagenesis Kit, Stratagene, cat no. 200517-4, lot no. 006047569) are designed for 
efficient transformation of large DNA molecules. The XL-10 Gold strains are also 
designed to allow cloning of methylated DNA and aids in producing higher quality of 
miniprep DNA. The XL-10 Gold Ultracompetent cells stored at -80°C were gently 
thawed on ice. 50 µL of the Gold Ultracompetent cells were aliquoted to a prechilled 
14-mL BD Falcon polypropylene round-bottom tube (Becton Dickinson, catalog no. 
352059) for 30 minutes. 1 µL of the DpnI treated DNA was added to the cells in the 
Falcon tube on ice for few minutes. The transformation reaction was heat shocked at 
42°C for 45 seconds. The reaction tubes were placed on ice for 2 minutes. 0.5 mL of 
SOC media preheated at 42°C SOC media was added to the transformation tubes and 
the tubes were incubated at 37°C for 1 hour in a shaking incubator at 225 rpm. After 
the 1 hour incubation, 250 µL of the transformation reaction was plated on two 
nutrient agar (NA) plates containing ampicillin (100 µg/mL), and 48 µL X-Gal. The 
plates were then incubated at 37°C for> 16 hours. 
The nutrient agar (NA) plates were checked for the growth of white colonies. 
The white colonies were restreaked in nutrient agar plates containing ampicilin ( 100 
µg/mL) and incubated overnight at 37°C. 
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Plasmid Purijicatio11 
The purpose of this step was to purify the pIX-2 plasmids containing the 
umuD cleavage and nucleophilic activator residue mutations so that they could be 
then transformed into E.coli wild type (AB1157) and umuD (315) competent cells 
where the mutated gene would be expressed. The QIAprep® Spin Miniprep Kit 
(QIAGEN Sciences, catalog no. 27106) was used to purify the plasmids from the 
overnight cultures of the transformed XL-10 Gold Ultracompetent cells. Several 
microcentrifuge tubes were filled with 1 mL of double distilled H2O ( ddH2O). 
Applicator tips were used to acquire colonies from the overnight plate cultures and 
colonies were transferred into the microcentrifuge tubes containing sterile water and 
resuspended. The tubes were centrifuged for 2 minutes at 14,000 rpm. The 
supernatant was discarded. The bacterial pellets were resuspended in 250 µL Buffer 
Pl (stored at 4°C) containing 100 µg/mL of RNAse A. 250 µL of Buffer P2 was 
added and gently and thoroughly mixed by inverting the tubes 4-6 times. 350 µL of 
Buffer N3 was added and immediately mixed thoroughly by inverting the tubes 4-6 
times. The solution became cloudy at this point. The tubes were centrifuged for 10 
minutes at 13,000 rpm. A white compact pellet was seen in the tubes after 
centrifugation. The supernatants from the tubes were applied to QIAprep spin 
columns by pipetting and centrifuged for 1 minute. The flow-through was discarded. 
0.75 mL of the Buffer PB was added to the QIAprep spin columns and centrifuged for 
1 minute. The flow-through was discarded and centrifuged for an additional minute to 
get rid of the excess wash buffer in the columns. The QIAprep columns were placed 
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in new microcentrifuge tubes and 30-50 µL of EB (Elution Buffer) was added to the 
center of the QIAprep column. The tubes were let stand for 1 minute and centrifuged 
for I minute at 13,000 rpm. The concentration of the plasmids was measured using a 
NanoDrop spectrophotometer (ND-1000, NanoDrop Technologies) and the plasmids 
were stored at 4°C. 
Co1ifir111atio11 of the 111utatio11s 
To confirm the presence of the mutations in plX-2, samples of the plasmids 
containing the predicted cleavage and nucleophilic activator residue mutations were 
either digested with Ddel restriction enzyme or sent to Alpha Biolaboratory in 
Burlingame, California for DNA sequencing. Ddel could confirm the Gly to Glu 
predicted cleavage mutation because a restriction site was created as a result of the 
mutation, which resulted in additional DNA fragment when the samples were run in 
agarose gel. 
Tra11sfor111atio11 of co111pete11t wild type a11d umuD E. coli 
Transforming the AB II 57 and 315 strains with the purified plasmids 
containing the mutated cleavage or nucleophilic activator residues in umuD enables 
us to study the expression of the mutated gene products in wild type and umuD E. coli 
strains. 200 µL of each frozen CaCh competent ABll57 & 315 cells (made 
competent in Hare lab) were transferred to a pre-chilled 14-mL BD Falcon 
polypropylene round-bottom tube. I µL of the purified and stored plasmid from the 
purification step was added to the two Falcon tubes on ice for 30 minutes. The tubes 
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were then transferred to a 42°C water bath for 90 seconds. The tubes were 
immediately transferred to an ice bath and the reactions were allowed to chill for 2 
minutes. 800 µL of preheated SOC medium was added to the tubes. The tubes were 
incubated in a 37°C incubating shaker for 45 minutes at 225 rpm to allow the 
bacterial cells to recover and express ampicillin resistance. After incubation, the tubes 
were centrifuged for a minute at 15000 xg and all of the liquid was plated on a 
nutrient agar (NA) plate containing 100 µg/mL of ampicillin per tube. 
Co11jir111atio11 of plasmid prese11ce i11 cells 
Since the plasmids pIX3.0 and pffil contain an ampicillin resistance (ampR) 
gene as a selectable marker, only the competent cells that contain the plasmid with 
the ampR gene are able to survive in ampicillin-containing medium. ampR functions 
by encoding for a protein that makes the cells transformed with the plasmids resistant 
to antibiotic ampicillin. 
Storage of bacterial cultures 
The purpose of this step was to store the transformed bacterial cultures 
appropriately so that these cultures can be used in the future. Overnight cultures of 
bacterial strains were grown in tubes containing 3 mL of Luria-Bertani (LB) broth 
and 3 µL (100 mg/mL) of ampicillin. The following day the culture tubes were 
vortexed and 750 µL of the liquid cultures were transferred to appropriately labeled 
microcentrifuge tubes. 250 µL of sterile 60% glycerol was mixed into the 
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microcentrifuge tubes containing the liquid cultures. The tubes were vortexed briefly 
and stored at -80°C. 
Collection of E. coli cell Iysates and guantitation of protein 
Lysate preparatio11 
Crude, total protein cellular lysates were prepared from overnight cultures 
grown in 3 mL of LB broth added with ampicillin (100 µg/mL) in a 37°C shaking 
incubator. 3 mL of the overnight cultures were 1: 10 diluted in 25 mL of LB plus 
ampicillin ( 100 µg/mL) in an Erlenmeyer flask and grown at 3 7°C with shaking at 
200 rpm for an additional 3 hours. After 3 hours, 12.5 mL of the cultures was 
transferred to a new each flask and 12.5 µL ofmitomycin C (+MMC) (2 µg/mL) was 
added to the new flask. MMC is a potent DNA cross-linker, and induces DNA 
damage in our experimental setup. Both cultures were grown for additional necessary 
time (minutes to hours). Samples 1.5 mL were then collected in microcentrifuge tubes 
from either the "+MMC" or "-MMC" at the following increments: 0 minutes, 15 
minutes, 30 minutes, 45 minutes, and 60 minutes. Each sample was spun for 3 
minutes at 15,000 rpm. The supernatant was decanted and each pellet was 
resuspended in a solution of950 µL Laemmli buffer (63 mM Tris HCI, 10% glycerol, 
2% SDS, 0.0025% bromophenol blue, pH 6.8) and 50 µL of 2-mercaptoethanol 
(Sigma Chemical Co., lot no. 129 F04061). The samples were stored in the -20°C 
freezer and boiled for 5 minutes and placed in ice for 5 minutes before use. 
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Protein Qua11titatio11 Assay 
To ensure that constant amounts of proteins from the lysates were loaded in 
each gel, we performed the RC DC Protein Assay (Bio-Rad). 5 µL of DC Reagent S 
was added to each 250 µL of DC Reagent A (Bio-Rad, catalog no. 500-0113) 
resulting in a mixture called Reagent A'. Five dilutions of a protein standard, bovine 
plasma gamma globulin (Bio-Rad, catalog no. 500-0005, purchased in solution as part 
of the Bio-Rad protein quantitation assay kit), were prepared by dilution in Lemmaeli 
buffer. The resultant concentration of the protein ranged· from 0.2 mg/mL to 1.5 
mg/mL. These diluted proteins were used to prepare a standard curve each time the 
assay was performed. 25 µL of standards or lysate sample was placed in a clean 
microfuge tube containing 125 µL of Reagent A'. 125 µL of RC Reagent I (Bio-Rad, 
catalog no. 500-0117) was added to each tube. The tubes were vortexed briefly and 
incubated for I minute at room temperature. 125 µL of RC Reagent II (Bio-Rad, 
catalog no. 500-0118) was added to each tul:>e, vortexed briefly, and centrifuged at 
15,000 g for 3-5 minutes. The supernatants were discarded and the liquid was allowed 
to drain completely from the tubes. 127 µL of Reagent A' was added to each tube and 
vortexed. The tubes were incubated at room temperature for 5 minutes or until the 
precipitate was completely dissolved. The tubes were vortexed, 1 mL of DC Reagent 
B (Bio-Rad, catalog no. 500-0114) was added to each tube and vortexed immediately 
again. The tubes were incubated at room temperature for 15 minutes. The 
absorbances were recorded at 750 nm with the relative blue color of intensity 
correlating with increasing protein. A standard based on the readings from the BSA 
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standards was created and the amount of protein m each lysate sample was 
determined. 
Western Immuno-blot and analysis of proteins 
Either a Mini-PROTEAN® TGX™ gel (4-20% Tris-HCI, Bio-Rad) or a 
Criterion™ Precast gel (10-20% Tris-HCI, 1.0 mm, BIO-RAD) was run in order to 
separate various proteins by size. Frozen lysates were boiled for 5 minutes and put on 
ice for 5 minutes each time a PAGE was performed. The amount of protein samples 
ranging from 1.75 µg to 12 µg (determined from RC DC Assay) were loaded in the 
gel. The amount of protein corresponds to the micrograms (µg) of total protein per 
lane. The gel was run for 1 hour at 125 volts for a Mini-PROTEAN® gel or 3 hours at 
125 volts for the Criterion™ gel at 4 °C. The gel running buffer was composed of: 25 
mM Tris base, 192 mM glycine, and 10% SDS. 
After running the gel for an appropriate time, the proteins in the gel were 
transferred to an Immun-Blot PVDF membrane (Immun-Blot™ PVDF Membrane, 
Bio-Rad, lot no. D103267 for 10 x 15 cm or Immun-Blot™ PVDF Membrane, Bio-
Rad, lot no. BR0028003 for 7 x 8.4 cm) using the Trans-Blot apparatus (Bio-Rad, 
Criterion™ Blotter). The apparatus was run for I hour at 100 volts at 4°C with 
transfer buffer (25 mM Tris base, 192 mM glycine, 10% methanol (Fisher Scientific, 
lotno. 107631)). 
After the protein was transferred to the membrane, the membrane was air 
dried, pre-wetted in 100% methanol and incubated overnight in 0.05% Tween-20 
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(Bio-Rad, catalog no. 170-6531) in Tris Buffered Saline (TBS) (25 mM Tris, 137 mM 
NaCl, 2.7 mM) containing 5% milk (Blotting grade blocker non-fat dry milk, Bio-
Rad, catalog no. 170-6404) on a Belly Dancer (Stovall Life Sciences Inc.) at speed 2 
at 4°C. The following day, the membrane was incubated in 0.05% TBS Tween-20 
containing 2.5% milk and diluted primary antibody. 
Primary antibodies used were either an anti-peptide antibody directed at a 15 
amino acid peptide located 79 amino acids upstream of the predicted cleavage site 
(Figure 9) or polyclonal antibody. The polyclonal anti-UmuD antibody was prepared 
by GenScript Corp., New Jersey, USA. Purified UmuDAb proteins were constructed 
by GensScript from the umuDAb sequence and the proteins were injected in rabbits. 
The serum containing the anti-UmuD polyclonal antibody were then isolated from the 
rabbits. Anti-peptide 2 (peptide specific) or polyclonal anti-UmuD antibodies were 
used at a dilution of 1:10,000, and secondary antibody (Goat Anti-Rabbit HRP 
Conjugate, Bio-Rad, catalog no. 170-5046) was used at dilution of 1 :32,000. All 
antibody incubations were carried out separately for 1 hour each. The membrane was 
washed five times with 0.01% TBS-Tween 20 for 10 minutes in between the primary 
and secondary antibody incubation and after secondary antibody incubation. Precision 
StrepTactin-HRP Conjugate (Bio-Rad, catalog no. 161-0380) at a dilution of 1:i0,000 
was added with the secondary antibody. The secondary antibody is linked to an 
enzyme horseradish peroxidase (HRP) and binds to the primary antibody. The HRP 
cleaves a chemiluminescent substrate, resulting in generation of luminescence 
proportional to the quantity of protein present in the membrane. Chemiluminescent 
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substrate (SuperSignaI® West Pico Chemiluminescent Substrate, Thermo Scientific, 
lot no. LC 141629) was prepared for the membrane and was gently pipetted onto with 
the PVDF membrane. After incubating in the dark with the substrate for 10 minutes, 
the film was sandwiched between transparency papers. The membrane sandwich was 
placed into an X-ray film cassette and the orientation was marked. The membrane 
was exposed to X-ray film in a medical film processor (Konica Minolta, SRX-101A, 
Z & Z Medical, Inc.) for different time exposures and the film was developed with 
developer (Med-Dent Developer, White Mountain Imaging, catalog no. 2501-FG) and 
fixer (Med-Dent Developer, White Mountain Imaging, catalog no. 2502-FG). 
MSOdNKNEHGGARTNAGRKlAK.YQEPTKVIRVPESQVAFIKRWLLDNVKTDN 
LIDFNSALKVQAIQPNPTKIYQIPLATERV MGtPSPAQEHVEQSLDLNEYL VR ...... 
NENA TFIVKANSLSMLDAGIDIDDPLIVDRSITAKAGDIVIAMVDNEFTVKRLI 
DHHFHPPKVWLKAENPDFQNIYIDEGQEL VIWGVVTYNLKPMR 
Figure 9. Sequences recognized by anti-peptide antibody. Primary anti-peptide 
antibody recognizes the 15 amino acids (shown in box) upstream of the predicted 
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Figure 10. Steps involved in a Western blotting technique. Adapted from Lodish, 2008. 
Results 
The main objective of my research was to determine if the UmuDAb protein 
was being expressed in wild type and umuD mutants of E. coli, and was self-cleaving 
over time after the cells were treated with a DNA damaging agent. In addition, we 
also wanted to determine if the mutations in the predicted cleavage or nucleophilic 
attack residues blocked or inhibited the disappearance (cleavage) of the protein over 
time. Therefore, Western blot analysis was performed and observations made were 
compared with E. coli model for similarities and contrasts. 
The umuD found in ADPI is about 1.5 times the size of umuD in E. coli and 
other bacteria and research has shown that the functioning of the umuDAb encoded 
gene product is unlike other bacteria such as E. coli (Hare et al., 2006). Western blot 
analyses performed in Hare lab have shown the size of the protein to be 
approximately 23 kDa (Experiments in Hare lab and this study). The pJHI plasmid 
containing the native promoter expresses the -23 kDa protein. The plX-2 plasmid 
containing the constitutive promoter also expresses the protein of-23 kDa. 
Table 6 shows features ofUmuD participation in E.coli. My objectives of the 
thesis are to address similar processes or features in ADP!. Different approaches have 
been taken to investigate these features in ADP I. In E. coli, UmuD self-cleaves in a 
reaction mediated by *RecA after DNA damage (Shinagawa et al., 1988; Burckhard! 
et al., I 988) and to investigate if UmuDAb self-cleaves in response to DNA damage, 
umuDAb will be expressed in umuD strains of E. coli. In order to examine RecA 
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involvement in the disappearance (cleavage) of UmuDAb, UmuDAb will be 
expressed in DH5a and AB2463 cells that lack recA gene and these cells will be 
treated with MMC. The apparent cleavage time scale ofUmuDAb will be calculated 
as the half-life after the cells expressing UmuDAb are treated with MMC. To 
examine the predicted cleavage site of UmuDAb, the glycine residue at the predicted 
cleavage site of the protein at A83 -G84 site will be mutated to glutamic acid. Similarly, 
the conserved lysine residue that acts in E. coli as a nucleophilic activator will be 
mutated to alanine to observe its effects in the cleavage of the protein. 
Table 6. Features of the E.coli involvement ofUmuD in the SOS mutagenesis of 
DNA damage response 
Processes/Features of E.coli Reference(s) 
UmuD cleavage 
RecA involvement Requires RecA Witkin. 1976; 
Walker, 1984; 
Perry et al., 1985 
Shinagawa et al., 1988 
Burckhard! et al., 1988 
Cleavage time scale -20 min after DNA Opperman et al., 1999 
damaee 
Cleaved where? C,.-G,, Nohmi et al., 1988 
Amino acids required for Ser, & Lys Nohmi et al., 1988 
cleavaee 
SOS mutagenesis C,.-G,, Cleavage, Ser, & Nohmi et al., 1988 
phenotype required Lys 
UmuD involvement UmuD self cleavage Burkhardt et al., 1988; 
Nohmi et al., 1988; 
Shinagawa et al., 1988; 
Paetzel and Woodgate, 
2004 
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UmuDAb protein is expressed in E. coli 
Wild type cells express UmuDAb, which disappears over time after MMC treatment 
Western analysis showed that UmuDAb of ADP! is expressed in the wild type 
E. coli strain AB 1157 and the size of the protein is approximately 23 kDa as predicted 
by the open reading frame (Hare et al., 2006) (Figure 8). The expression of the 
protein disappeared over time in cells treated with 2 µg/mL of MMC, whereas the 
levels ofUmuDAb were consistent over time in non-MMC treated cells. The apparent 
"disappearance" of UmuDAb (Figure 11, lanes 2 and 3) could be as a result of 
cleavage of the protein at the predicted cleavage site in response to MMC-induced 
DNA damage because when anti-peptide antibody is used, the larger ~16 kDa 
expected cleavage product cannot be expected to be seen or recognized on the 
Western blot. This is because primary anti-peptide antibody recognizes the 15 amino 
acids (shown in box) upstream of the predicted cleavage site (Figure 9). 
A cross-reacting protein of approximately 19 kDa is seen in the Western blot 
(Figure 11, lanes 2, 3, 4, 5, 6, and 7; and Figure 12 A and B, lanes 3-18 for both). 
Furthermore, AB 1157 cells alone can express the cross-reacting protein (Data not 
shown, personal communication with M. Whitaker of Hare lab). The 19 kDa protein 
is neither UmuD nor UmuDAb because the molecular weights of UmuD and 
UmuDAb are 15.0 (Kitagawa et al., 1985) and 23.0 kDa respectively. The control 
cells that contain the vector alone with no umuDAb do not express UmuDAb but the 
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Figure 11. Expression and disappearance or no disappearance ofUmuDAb in wild type, umuD, and recA 
strains of E. coli. The cells were treated with MMC for 1 hour. "+" indicates cells treated with 2 µg/mL of MMC, 
"-" refers to no MMC treatment. Primary antibody used was anti-peptide 2. Lanes 8 and 9 contain proteins from 
wild type with vectors pUC19 and pIX3.0, alone respectively. 
E.coli UnmD is 11ot required for UmuDAb disappeara11ce after DNA damage 
Western blot analysis indicated that UmuDAb was also expressed in E. coli 
cells that completely lack their umuD gene. The size of the expressed protein was 
approximately 23 kDa. UmuDAb disappeared over time in MMC unttreated cells in a 
time-dependent manner whereas the amounts of the protein were consistent over time 
in non-MMC treated cells (Figure 12 A and B). Because the umuD E. coli completely 
lack the umuD gene that encodes its own UmuD (Personal communication with P. 
Buening), and UmuDAb disappeared over time in MMC treated cells, we conclude 
that E. coli UmuD is not required for or involved in UmuDAb disappearance. 
UmuDAb disappears i11 both wild type a11d umuD strai11s ofE. coli 
In order to examine the phenomenon of disappearance of UmuDAb more 
closely with respect to its timing, more short-term protein lysates were collected after 
MMC treatment. Figure 12 A and B suggest that UmuDAb is expressed, but 
disappears after MMC-induced DNA damage over similar amounts of time in both 
wild type and umuD strains of E. coli. UmuDAb was expressed and the protein 
disappears over time with MMC treatment. This suggests that MMC acts as a DNA 
damaging agent and UmuD is self cleaving, which is consistent with E. coli model. 
Other experiments in the Hare lab (Personal communication with S. Wheeler and K. 
Lambert of Hare lab) also have shown that UV-C exposure causes disappearance 
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Figure 12 A. Expresssion of UmuDAb in wild type E. coli. UmuDAb is expressed from pIX-2 and 
disappears over time in wild type with MMC treatment. "+" indicates cells treated with 2 µg/mL of MMC, 
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Figure 12 B. Expresssiou of UmuDAb iu umuD strains of E. coli. UmuDAb is expressed from pIX-2 and 
disappears over time in umuD mutants with MMC treatment. "+" indicates cylls treated with 2 µg/mL of MMC, "-" 
refers to no MMC treatment. Primary antibody used was peptide-specific anti-peptide 2 antibody. 
Timing ofUmuDAb disappearance resembles that ofE. coli 
In order to compare the disappearance of UmuDAb in wild type and umuD 
strains of E. coli in a more quantitative manner such as to see if the protein cleave 
with same timing, ImageJ Software (National Institutes of Health) was used to 
determine the percent of UmuDAb remaining after DNA damage. The percent 
remaining was calculated at different intervals of times after addition of MMC to the 
cultures: 0 minutes, 5 minutes, IO minutes, 15 minutes, 20 minutes, 25 minutes, 30 
minutes, 45 minutes, and 60 minutes. The decay ofUmuDAb for all the experiments 
was calculated to be -20 minutes, which is similar to - 20 minutes (Opperman et al., 
1999) for E. coli. The timing of disappearance of the protein was determined as a 
half-life time from a percent remaining versus time (min) graph for the protein as 
shown in Figure 13. 
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Figure 13. Half -life of UmuDAb protein. Percentage of UmuDAb remaining over time manner in both MMC 
treated and untreated samples of wild type and umuD strains of E. coli expressing UmuDAb. The horizontal and 
vertical dotted lines represent the halflife for the disappearance ofUmuDAb in wild type and umuD E. coli. 
RecA is required for the cleavage ofUmuDAb 
In E. coli, RecA is activated by DNA damage to subsequently bind to UmuD 
and facilitate its self-cleavage (Shinagawa et al., 1988; Burckhardt et al., 1988). To 
assess the role of RecA in the disappearance of UmuDAb, UmuDAb disappearance 
was examined in the DH5a recA strain of E. coli that was used to produce pIX-2. 
The wild type and recA strains of E. coli were grown for > 16 hours, then I: IO diluted 
and grown for additional 3 hours. The cells were then treated with MMC for I hour. 
In wild type and umuD strains, UmuDAb disappears after a I hour treatment with 
MMC (Figure 14). In DH5a cells that are mutated in their recA gene, however, the 
level of UmuDAb expression was consistent over time and did not disappear. This 
suggests that RecA is required for the disappearance ofUmuDAb after DNA damage, 
and is consistent with the idea that the "disappearance" is cleavage. 
However, the DH5a strain of E. coli contains many additional mutations in its 
genotype, relative to AB 1157, in addition to recA, therefore it was necessary that we 
use an isogenic strain of wild type AB! 157 that has a mutation in its recA gene only. 
AB2463 is an isogenic strain of wild type AB 1157 with a mutation in its recA gene 
that encodes for RecA (Horii et al., 1979). To further assess the role of RecA in the 
disappearance of UmuDAb after DNA damage, AB2463 cells containing various 
plasmids such as pJHI, pIX-2 and pIX-1 were grown as described in Materials and 
Methods, and treated with MMC for I hour. The recA+ strain ABI 157 was also 
treated with MMC as a control. As shown in Figure 15, UmuDAb does not disappear 
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in recA strains after I hour MMC treatment. However, UmuDAb disappears in the 
recA+ strains, offering further evidence that RecA is required for the disappearance of 








100 I + I I ..... ..... 0\ 0 
+ I I + + ..... ,.,.., i5 I >:: >:: I 0 ' .......... - ..... I I ..... <"l <"l ::i >:: :~ ~ Q., Q., ~ + ..... I I I ..... 50 r-- r-- I ' ..... >:: >:: >:: >:: Q., Q., 
! s s in Ir) >:: >:: ..... ..... .._. ..... r-- r-s s ,... s ..... ..... ..... ...... s Ir) in 3i : :fl :fl ,... Q., ..... ..... ..... ..... -~ ~ in Ir) in in in in ..... ..... ..... ..... ::i:: ::i:: ::i:: ::i:: ~ ~ ·o o -:i: ,.,.., ,.,.., A Q Q Q -:i: 25 -•-·.,·. --20 
-.- :-.,, 
15 
10 -!' " Lanes 2 3 4 5 6 7 8 9 10 11 12 13 
Figure 14. Expression of UmuDAb in recA- and recA+ strains of E. coli. Western blot analyses showing the 
expression and disappearance or no disappearance of UmuDAb in DH5a recA- and recA+ strains after cells were 
treated with MMC for I hour. "+" indicates cells treated with 2 µg/mL of MMC, "-" refers to no MMC treatment. 
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Figure 15. Disappearance ofUmuDAb in recA+ strains of E.coli. Western blot analyses showing the expression 
and disappearance or no disappearance of UmuDAb in AB2463 recA· and AB 1157 recA+ strains after cells were 
treated with MMC for 1 hour. "+" indicates cells treated with 2 µg/mL of MMC,"-" refers to no MMC treatment. 
The vector used was pIX3.0. 
UmuDAb mutant in predicted cleavage site still disappears in time-dependent 
manner after MMC treatment 
To test whether the observed disappearance ofUmuDAb was really a result of 
the cleavage in the predicted cleavage site of the protein, I constructed a mutation in 
the predicted cleavage site of the protein at A 83 -G84 site. The glycine at the predicted 
cleavage site was mutated to glutamic acid because by changing the Gly-25 residue of 
the putative Cys-Gly cleavage site to a glutamic or lysine residue in E. coli UmuD 
significantly reduced the ability ofUmuD to function in SOS mutagenesis (Nohmi et 
al., 1988). 
Proteins lysates were prepared from the wild type and umuD E. coli as 
described in the Materials and Methods and examined with Western blot analyses 
with a polyclonal antibody directed against the entire UmuDAb protein. 
Figure 16 shows the effect of the predicted cleavage site Gly-84 to Glu-84 
mutation on the disappearance of UmuDAb. Wild type that contained the plasmids 
with the predicted Gly-84 to Glu-84 cleavage mutations in umuDAb express the 
protein, which similar to the unmutated UmuDAb, almost completely disappears at 
60 minutes with MMC treatment (Figure 16, lanes 6 and 7). Similar results were seen 
in the umuD strain background: the mutated UmuDAb protein still disappeared after 
60 minutes of MMC treatment (Figure 16, lane 9). 
This first immunoblot, shown in Figure 16 was performed on sample lysates 
collected at O minutes and 60 minutes only. To obtain better observations on the 
disappearance of an UmuDAb, immunoblot was re-run with lysates collected on 
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different dates at 0 minutes, 30 minutes, 45 minutes, and 60 minutes. Moreover, the 
primary antibody used this time was polyclonal antibody that recognizes the entire 
UmuDAb unlike peptide-specific antibody that is sequence specific directed at a 15 
amino acid peptide located 79 amino acids upstream of the predicted cleavage site 
(Figure 9). This is desirable because the polyclonal antibody is directed against the 
whole UmuDAb protein and therefore also recognizes the.cleaved UmuD' product. 
Figure 17 shows the effect of the predicted cleavage site Gly-84 to Glu-84 
mutation on the disappearance ofUmuDAb. The levels ofUmuDAb in either the wild 
type or umuD strains were consistent in cells that were not treated with MMC (Figure 
17, lanes 2, 4, and 6 or lanes 13 and 15). The un-mutated UmuDAb expressed by the 
wild type and umuD strains disappeared over time with MMC treatment (Figure 17, 
lanes 2, 3, and 5 or lanes 13, and 14). Wild type cells that contain the plasmids with 
the predicted Gly-84 to Glu-84 cleavage mutations in umuDAb express the protein, 
which completely disappears at 60 min with MMC treatment (Figure 17, lanes 7, 8, 
and 10). Similar results were seen in the umuD strain background: the UmuDAb 
cleavage mutants still disappeared after 60 min of MMC treatment. 
In contrast to the results seen in Figure 16, with the use of polyclonal 
antibodies, we see a -14 kDa cleavage product appearing in only MMC treated cells, 
which may correspond to a UmuD' form (Figure 17, lanes 3, 5, 8, 10, and 16). The 
larger molecular weight, -16 kDa of cleavage product for cleavage mutants suggests 
that UmuDAbG84E might be using an alternate cleavage site. Figure 18 shows the 
percentage ofUmuDAb remaining in a time-dependent manner in both MMC treated 
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Figure 16. Expression of UmuDAb by wild type and umuD predicted cleavage mutants. "+" indicates cells 
treated with 2 µg/mL of MMC, "-" refers to no MMC treatment. The primary antibody used was peptide-specific 
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Figure 17. Expression ofUmuDAb by wild type and umuD predicted cleavage mutants."+" indicates cells 
treated with 2 µg/mL of MMC,"-" refers to no MMC treatment. The primary antibody used was polyclonal 
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Figure 18. The percentage of UmuDAb remaining in a time-dependent manner in both MMC treated and 
untreated samples of wild types and cleavage mutants. The solid lines represent the UmuDAb in samples 
untreated with MMC while the dotted lines represent the UmuDAb in samples treated with MMC. 
UmuDAb mutant in nucleophilic activator residue fails to undergo cleavage after 
treatment with MMC 
Because the UmuDAb expressed by the cleavage mutants disappeared 
surprisingly after MMC-induced DNA damage (Figure 16 and 17), we speculate that 
the protein cleaves in a site rather than the predicted cleavage site or the protein uses 
alternate mechanism for the cleavage. Therefore, I constructed a mutation in the 
lysine residue (Lys-156) of the UmuDAb that acts as a nucleophilic activator for the 
cleavage mediated by serine. The lysine at the nucleophic activator residue was 
mutated to alanine because by changing the Lys-97 residue to alanine in E. coli 
UmuD drastically reduced the ability of UmuD to function in SOS mutagenesis 
(Nohmi et al., 1988). 
Proteins lysates were prepared from the wild type and umuD E. coli as 
described in the Materials and Methods and examined with Western blot analyses 
with a polyclonal antibody directed against the entire UmuDAb protein. 
In Figure 19 A and B, we see that UmuDAb is expressed by wild type and 
umuD strains of E. coli and disappears in a time-dependent manner in MMC treated 
wild type and umuD mutants, disappearing completely at 60 min. This disappearance 
is dependent on MMC treatment, as UmuD does not disappear in MMC untreated 
cells. 
Figure 19 A and B show that UmuDAb that is mutated in its nucleophilic 
activator residue (Lys-156 to Ala-156), is also expressed by wild type and umuD 
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mutants of E. coli. However, UmuDAb containing the nucleophilic activator residue 
mutation does not disappear over time after MMC treatment in either in wild type or 
umuD mutants of E. coli. The levels of expression of UmuDAb is consistent over 
time in both MMC-treated and untreated samples of wild type and umuD mutants. 
This suggests that the "disappearance" is actually cleavage, mediated by a reaction 
like that of other peptidases such as LexA and UmuD, which depend on the Lys-Ser 
enzymatic dyad (Figure 7). 
Figure 20 represents a graph that shows the percentage of UmuDAb 
remaining in a time-dependent manner in both MMC treated and untreated samples of 
wild type and nucleophilic activator residue mutants whereas Figure 21 represents a 
graph that shows the percentage ofUmuDAb remaining in a time-dependent manner 
in both MMC treated and untreated samples of umuD mutants and nucleophilic 
activator residue mutants. Figure 20 shows that the levels of UmuDAbKtoA is 
consistent over time in the wild type nucleophilic activator residue mutants treated 
with MMC while the UmuDAb has completely disappeared in wild type cells after 
MMC treatment. Similarly, Figure 21 shows that the levels of UmuDAbKtoA is 
consistent over time in umuD nucleophilic activator residue mutants after MMC 
treatment while the protein has completely disappeared in umuD cells that express 
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Figure 19 A. Expression of UmuDAb by wild type nucleophilic activator residue mutants. "+" indicates cells 
treated with 2 µg/mL of MMC, "-" refers to no MMC treatment. The primary antibody used was polyclonal 
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Figure 19 B. Expression of UmuDAb by umuD nucleophilic activator residue mutants. "+" indicates cells 
treated with 2 µg/mL of MMC, "-" refers to no MMC treatment. The primary antibody used was p6lyclonal 
antibody that recognizes the entire UmuDAb. 
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Figure 20. Graph showing the percentage of UmnDAb remaining in a time-dependent manner in both MMC 
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Figure 21. Graph showing the percent ofUmuDAb remaining in a time-dependent manner in both MMC 
treated and untreated samples of umuD mutants and nucleophilic activator residue mutants. The solid lines 
represent the percent ofUmuDAb in samples untreated with MMC while the dotted lines represent the percent of 
UmuDAb in samples treated with MMC. 
What we know now of A. baylyi model system 
Table 7 contains the summary of results after numerous Western blot analyses 
were performed to better understand the role and action of UmuDAb action after 
DNA damage response. Most of the processes or features of UmuDAb action after 
DNA damage have been addressed while some of the features still need to be 
determined, which will be the basis of future experiments. 
Table 7. Processes/features observed in E. coli model system and that were 
addressed in this study. 
Processes/Features E. coliUmuD A. baylyi UmuDAb 
RecA involvement Requires RecA Requires RecA 
Cleavage Time Scale -20 min -20min 
Cleaved where? C'"-G" Not the predicted A 00 -G •• 
Amino acids required for Ser, & Lys L ys is required 
cleavage Ser-no data 
Phenotype required for SOS C'" -G·' Cleavage No data 
mutagenesis viaSer&Lys 
UmuD involvement UmuD self cleavage E. coli UmuD is not 




Various endogenous or exogenous factors can damage DNA, and in order to 
sense and repair these damages, cells have developed a variety of DNA damage repair 
mechanisms. As already mentioned above, there are two main ways by which cells 
can sense and repair damages: error-free repair and error-prone repair mechanisms. A 
cell's repair machinery is always on lookout attempting to fix these DNA damages 
and a cell may have the following three fates as a result of this attempt to deal with 
DNA damages: 1) the damaged DNA is repaired perfectly by error-free DNA repair; 
2) the cell may undergo programmed cell death or apoptosis if the damage cannot be 
fixed or if the repair is partial; and 3) the cell may carry out error-prone repair with 
elevated levels of mutation loads in DNA. 
When the levels of DNA damage is so extensive that error-free DNA repair, 
such as BER, NER, and _recombinational DNA repair (Friedberg et al., 2006) cannot 
repair the damage, DNA replication is stalled. This triggers the mutagenic phase of 
the SOS response (Walker, 1984; Echols and Goodman, 1990), also known as SOS 
mutagenesis that leads to translesion synthesis (TLS) (Bridges and Woodgate, 1985; 
Goodman, 2002). 
After DNA damage, single-stranded DNA generated by a halt in replication 
converts a key regulatory protein RecA to its activated form (RecA *), which 
facilitates the autocleavage of LexA repressor and induces several SOS genes such as 
umuD, umuC, polB, recN, su/A, uvrB, and uvrD to be expressed (Friedberg et al., 
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1995). LexA represses the expression of umuD and umuC genes by binding to a "SOS 
box" (Mount et al., 1972). RecA * also facilitates the self-cleavage of UmuD to its 
cleaved form UmuD', which can complex with UmuC to form the error-prone DNA 
polymerase V (Tang et al., 1999) that carries out SOS mutagenesis. UmuD2C 
complex acts as checkpoint inhibitor of cell division by slowing down the cell cycle 
and allowing more time for error-free mechanism to act (Opperman et al., 1999). 
UmuD protein may play a role in shutting off SOS response by binding with UmuD' 
and forming a heterodimer UmuDD'C complex (Battista et al., 1990). 
The umuDAb gene found in ADPl has an extra N-terminus region unlike E. 
coli. However, bacteria such as Synechococcus elongatus, Legionella penumophila 
strain Lens and Chromobacterium violaceum have "extra-long" UmuD similar to 
ADPl (Figure 8). The umuDAb gene of ADP! is 612 bp long and encodes a protein 
of 203 amino acids, while umuD gene found in E. coli encodes 140 amino acids 
(Figure 5). The umuDAb is about 1.5 times the size of umuD in E. coli (Hare et al., 
2006). In E. coli, UmuD self-cleaves in a reaction mediated by *RecA after DNA 
damage (Shinagawa et al., 1988; Burckhardt et al., 1988) to carry out SOS 
mutagenesis. In this research, we were interested in investigating if UmuDAb also 
self-cleaves similar to E. coli UmuD in response to DNA damage. 
Multiple sequence alignment ofUmuDAb and UmuD homologs in E. coli and 
other bacteria show that many amino acids required for RecA mediated UmuD self-
cleavage in E. coli are conserved in UmuDAb (Figure 8). For example, the cysteine-
24/glycine-25 cleavage site, serine-60 that carries out the nucleophilic attack at the 
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UmuD cleavage site, and lysine-97 that acts as a nucleophilic activator are all 
conserved in UmuDAb. However, the multiple sequence alignment suggests that 
alanine-83/glycine-84 is the putative cleavage site in UmuDAb. We have thus created 
different types of mutations in either the predicted cleavage site or the residues that 
are required for effective cleavage in UmuDAb. The Gly-84 at the predicted cleavage 
site was mutated to Glu-84, while the Lys-156 that acts as a nucleophilic activator in 
UmuDAb cleavage was mutated to Ala-156. The mutated umuDAb genes were then 
transformed into E. coli wild type (ABl 157) and umuD (315) competent cells so that 
the mutated gene would be expressed and the functions ofUmuDAb could be studied. 
Western blot analyses in our lab have shown that UmuDAb is expressed in 
both wild type and umuD strains of E. coli. The size of the protein is -23 kDa as 
predicted by the open reading frame (Hare et al., 2006). The expression of the protein 
disappeared over time in both wild type and umuD strains of E. coli after MMC 
treatment (Figure 12 A and B). We have proposed that the apparent "disappearance" 
of UmuDAb was as a result of cleavage of the protein at the predicted alanine-
83/glycine-84 cleavage site in response to MMC-induced DNA damage. 
UmuD of E. coli self-cleaves post-trancriptionally in a reaction mediated by 
RecA to form UmuD'. A homodimer of UmuD' then complexes with a monomer of 
_ UmuC (Woodgate et al., 1989) to form a (UmuD')2C complex, an error-prone DNA 
polymerase V (Tang et al., 1999), which can conduct SOS mutagenesis in E. coli. 
Similarly, Western blot analyses have suggested that E. coli UmuD is not required for 
UmuDAb disappearance in response to MMC-induced DNA damage in umuD (315) 
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strains of E. coli. 315 strains of E. coli completely lack the umuD gene that encodes 
its own UmuD (Personal communication with P. Buening). Since the UmuDAb is 
expressed in umuD strains and disappears over time after MMC treatment (Figure 
12B, we conclude that UmuDAb is self-cleaving in response to DNA damage or at 
least E. coli UmuD is not required for UmuDAb cleavage. 
The timing of disappearance of UmuDAb was calculated to be -20 min 
(Figure 13). The disappearance timing was similar to that of E. coli UmuD, where 
after UV irradiation, uncleaved UmuD accumulates over UmuD' for 20 min. After 20 
minutes, UmuD' have been shown to accumulate while uncleaved UmuD slowly 
disappears (Opperman et al., 1999). Experiments in the Hare lab (Personal 
communication with S .. Wheeler and K. Lambert) also have suggested that UV-C 
exposure also causes apparent cleavage of UmuDAb in a way similar to the 
disappearance of UmuDAb in response to MMC-induced DNA damage. However, 
the timing of the disappearance of UmuDAb in response to UV-C-induced DNA 
damage has yet to be determined. 
RecA is activated by DNA damage in E. coli in response to DNA damage, 
which then binds to UmuD and mediates its self-cleavage (Shinagawa et al., 1988; 
Burckhard! et al., 1988). Similarly, our data clearly indicate that RecA is required for 
the cleavage of UmuDAb (Figure 14 and 15). UmuDAb is expressed by cells 
containing the native and constitutive promoter (Figure 14). UmuDAb disappears in 
recA+ (Figure 14, lanes 4 and 5; lanes 6 and 7) after MMC treatment of the cells for I 
hour. However, in recA· strains of E. coli (Figure 14, lanes 2 and 3; lanes 8 and 9; 
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lanes 10 and 11 ), the levels of UmuDAb is consistent after MMC treatment for I 
hour. Moreover, Western blot performed on AB2463, an isogenic strain of wild type 
ABl 157 that has recA mutation only, clearly suggested that RecA is required for the 
cleavage ofUmuDAb (Figure 15). UmuDAb does not disappear in recA- strains of E. 
coli after MMC treatment (Figure 15, lanes 6 and 7; lanes 9 and 10; lanes 12 and 13), 
while UmuDAb disappears in recA+ strains of E. coli. This suggests that RecA is 
required for cleavage of UmuDAb after MMC-induced DNA damage similar to the 
cleavage •Of UmuD in E. coli after DNA damage. 
The experiments ofNohmi et al., 1988 suggested that when the Gly-25 at the 
predicted cleavage site ofUmuD in E. coli to Glu-25, UmuD's ability to function in 
SOS mutagenesis was significantly reduced since the cleavage of the protein was 
tremendously blocked. In contrast, the mutation of Gly-84 residue in the predicted 
cleavage site of UmuDAb to Glu-84 did not reduce or block the cleavage of 
UmuDAb (Figure 16 and 17). The protein mutated at the predicted cleavage site still 
disappeared after wild type and umuD strains of E. coli after MMC treatment. 
Therefore, we speculate that the mutation does not affect the protein in its cleavage. 
Interestingly, a protein of ~16 kDa protein (Figure 17, lanes 8, 10, and 16) is also 
recognized by the polyclonal antibody that suggests that the· .protein may have found 
an alternate site for the cleavage. 
Nohmi et al., 1988 observed that when the nucleophilic activator residue, Lys-
97 was mutated to Ala-97, there was a substantial reduction in the amount of UV 
mutagenesis. The lysine residue is essential for the effective cleavage of UmuD in a 
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reaction mediated by a nucleophilic serine residue. Similarly, our data indicate that 
UmuDAb protein that has a mutation in its Lys-156 residue fails to undergo cleavage 
after MMC-induced DNA damage (Figure 19 A and B). This strongly suggests that 
lysine is a key amino acid essential in the effective cleavage of UmuDAb protein 
similar to that of E. coli VmuD. 
Table 7 summarizes the studies that were done as part of my research project. 
The data supports the hypothesis that UmuDAb self-cleaves in response to DNA 
damage as E. coli UmuD. Moreover, RecA is also required for the cleavage of 
UmuDAb as in E. coli. Furthermore, the data strongly suggest that Lys-156 is 
essential for the effective cleavage of UmuDAb in a mechanism similar to that of 
Lys-97 in E. coli UmuD. 
Future directions may involve studies with creating mutations in the alanine 
residue of the predicted cleavage site and serine residue that carries out the 
nucleophilic attack in the cleavage site. The mutated UmuDAb will be expressed in 
wild type and umuD strains of E. coli and the effect of these mutations on the 
cleavage of the protein will be studied. 
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